Page 196 - Read Online

and melanoma. J Neurooncol 2009;94:229-34. 91. Bakhshi S, Meel R, Kashyap S, Sharma S. Bone marrow aspirations
74. Bougel S, Lhermitte B, Gallagher G, de Flaugergues JC, Janzer RC, and lumbar punctures in retinoblastoma at diagnosis: correlation with
Benhattar J. Methylation of the hTERT promoter: a novel cancer IRSS staging. J Pediatr Hematol Oncol 2011;33:e182-5.
biomarker for leptomeningeal metastasis detection in cerebrospinal 92. Jennings MT, Gelman R, Hochberg F. Intracranial germ-cell tumors:
fluids. Clin Cancer Res 2013;19:2216-23. natural history and pathogenesis. J Neurosurg 1985;63:155-67.
75. Chamberlain MC, Johnston SK. Neoplastic meningitis: survival as a 93. Chang SM GA, Newton HB, Vogelbaum MA. Principles and practice
function of cerebrospinal fluid cytology. Cancer 2009;115:1941-6. of neuro-oncology. A multidisciplinary approach. Demos Medical
76. Shalaby T, Fiaschetti G, Baumgartner M, Grotzer MA. MicroRNA Publishing, LLC, New York 2011.
signatures as biomarkers and therapeutic target for CNS embryonal 94. Benesch M, Wagner S, Berthold F, Wolff JE. Primary dissemination
tumors: the pros and the cons. Int J Mol Sci 2014;15:21554-86. of high-grade gliomas in children: experiences from four studies
77. Baraniskin A, Kuhnhenn J, Schlegel U, Chan A, Deckert M, Gold R, of the Pediatric Oncology and Hematology Society of the German
Maghnouj A, Zollner H, Reinacher-Schick A, Schmiegel W, Hahn Language Group (GPOH). J Neurooncol 2005;72:179-83.
SA, Schroers R. Identification of microRNAs in the cerebrospinal 95. Wagner S, Benesch M, Berthold F, Gnekow AK, Rutkowski S, Strater
fluid as marker for primary diffuse large B-cell lymphoma of the R, Warmuth-Metz M, Kortmann RD, Pietsch T, Wolff JE. Secondary
central nervous system. Blood 2011;117:3140-6. dissemination in children with high-grade malignant gliomas and
78. Baraniskin A, Kuhnhenn J, Schlegel U, Maghnouj A, Zollner H, diffuse intrinsic pontine gliomas. Br J Cancer 2006;95:991-7.
Schmiegel W, Hahn S, Schroers R. Identification of microRNAs in 96. Walker DA PG, Punt JAG, Taylor RE. Brain and spinal tumors of
the cerebrospinal fluid as biomarker for the diagnosis of glioma. childhood. Abingdon, Oxon: CRC Press 2004.
Neuro Oncol 2012;14:29-33. 97. Forst DA, Nahed BV, Loeffler JS, Batchelor TT. Low-grade gliomas.
79. Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A Oncologist 2014;19:403-13.
systematic approach to the diagnosis of suspected central nervous 98. Sievert AJ, Fisher MJ. Pediatric low-grade gliomas. J Child Neurol
system lymphoma. JAMA Neurol 2013;70:311-9. 2009;24:1397-408.
80. Turner JD, Williamson R, Almefty KK, Nakaji P, Porter R, Tse V, 99. Moon JH, Jung TY, Jung S, Jang WY. Leptomeningeal Dissemination
Kalani MY. The many roles of microRNAs in brain tumor biology. of a Low-Grade Brainstem Glioma without Local Recurrence. J
Neurosurg Focus 2010;28:E3. Korean Neurosurg Soc 2012;51:109-12.
81. Wei D, Wan Q, Li L, Jin H, Liu Y, Wang Y, Zhang G. MicroRNAs 100. Hukin J, Siffert J, Velasquez L, Zagzag D, Allen J. Leptomeningeal
as Potential Biomarkers for Diagnosing Cancers of Central Nervous dissemination in children with progressive low-grade neuroepithelial
System: a Meta-analysis. Mol Neurobiol 2015;51:1452-61. tumors. Neuro Oncol 2002;4:253-60.
82. Shalaby T FG, Baulande S, Gerber NU, Baumgartner M, Grotzer 101. Leach PA, Estlin EJ, Coope DJ, Thorne JA, Kamaly-Asl ID. Diffuse
MA. Detection and quantification of extracellular microRNAs in brainstem gliomas in children: should we or shouldn’t we biopsy? Br
medulloblastoma. J Cancer Metastasis Treat 2015;1:67-75. J Neurosurg 2008;22:619-24.
83. Fuzery AK, Levin J, Chan MM, Chan DW. Translation of proteomic 102. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall
biomarkers into FDA approved cancer diagnostics: issues and JO. Exosome-mediated transfer of mRNAs and microRNAs is a
challenges. Clin Proteomics 2013;10:13. novel mechanism of genetic exchange between cells. Nat Cell Biol
84. Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, 2007;9:654-9.
Comabella M, Franciotta D, Frederiksen JL, Fleming JO, Furlan 103. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T,
R, Hintzen RQ, Hughes SG, Johnson MH, Krasulova E, Kuhle J, Schafer J, Lee ML, Schmittgen TD, Nana-Sinkam SP, Jarjoura D,
Magnone MC, Rajda C, Rejdak K, Schmidt HK, van Pesch V, Waubant Marsh CB. Detection of microRNA expression in human peripheral
E, Wolf C, Giovannoni G, Hemmer B, Tumani H, Deisenhammer F. blood microvesicles. PLoS One 2008;3:e3694.
A consensus protocol for the standardization of cerebrospinal fluid 104. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular
collection and biobanking. Neurology 2009;73:1914-22. organelles important in intercellular communication. J Proteomics
85. Phi JH, Lee J, Wang KC, Cho BK, Kim IO, Park CK, Kim CY, 2010;73:1907-20.
Ahn HS, Kim IH, Kim SK. Cerebrospinal fluid M staging for 105. Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body
medulloblastoma: reappraisal of Chang’s M staging based on the fluid: a new potential biomarker for cancer diagnosis and prognosis.
CSF flow. Neuro Oncol 2011;13:334-44. Cancer Sci 2010;101:2087-92.
86. Ho CY, VandenBussche CJ, Huppman AR, Chaudhry R, Ali 106. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T.
SZ. Cytomorphologic and clinicoradiologic analysis of primary Secretory mechanisms and intercellular transfer of microRNAs in
nonhematologic central nervous system tumors with positive living cells. J Biol Chem 2010;285:17442-52.
cerebrospinal fluid. Cancer Cytopathol 2015;123:123-35. 107. Rubenstein JL, Wong VS, Kadoch C, Gao HX, Barajas R, Chen L,
87. Parmar H, Hawkins C, Bouffet E, Rutka J, Shroff M. Imaging Josephson SA, Scott B, Douglas V, Maiti M, Kaplan LD, Treseler
findings in primary intracranial atypical teratoid/rhabdoid tumors. PA, Cha S, Hwang JH, Cinque P, Cyster JG, Lowell C. CXCL13 plus
Pediatr Radiol 2006;36:126-32. interleukin 10 is highly specific for the diagnosis of CNS lymphoma.
88. Zarovnaya EL, Pallatroni HF, Hug EB, Ball PA, Cromwell LD, Pipas Blood 2013;121:4740-8.
JM, Fadul CE, Meyer LP, Park JP, Biegel JA, Perry A, Rhodes CH. 108. Lai NS, Wu DG, Fang XG, Lin YC, Chen SS, Li ZB, Xu SS.
Atypical teratoid/rhabdoid tumor of the spine in an adult: case report Serum microRNA-210 as a potential noninvasive biomarker for the
and review of the literature. J Neurooncol 2007;84:49-55. diagnosis and prognosis of glioma. Br J Cancer 2015;112:1241-6.
89. Hilden JM, Meerbaum S, Burger P, Finlay J, Janss A, Scheithauer 109. Sasayama T, Nakamizo S, Nishihara M, Kawamura A, Tanaka
BW, Walter AW, Rorke LB, Biegel JA. Central nervous system H, Mizukawa K, Miyake S, Taniguchi M, Hosoda K, Kohmura E.
atypical teratoid/rhabdoid tumor: results of therapy in children Cerebrospinal fluid interleukin-10 is a potentially useful biomarker
enrolled in a registry. J Clin Oncol 2004;22:2877-84. in immunocompetent primary central nervous system lymphoma
90. Laurent VE, Sampor C, Solernou V, Rossi J, Gabri M, Eandi-Eberle (PCNSL). Neuro Oncol 2012;14:368-80.
S, de Davila MT, Alonso DF, Chantada GL. Detection of minimally 110. Fischer L, Korfel A, Pfeiffer S, Kiewe P, Volk HD, Cakiroglu H,
disseminated disease in the cerebrospinal fluid of children with Widmann T, Thiel E. CXCL13 and CXCL12 in central nervous
high-risk retinoblastoma by reverse transcriptase-polymerase chain system lymphoma patients. Clin Cancer Res 2009;15:5968-73.
reaction for GD2 synthase mRNA. Eur J Cancer 2013;49:2892-9. 111. Murase S, Saio M, Andoh H, Takenaka K, Shinoda J, Nishimura

186
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ May 18, 2016 ¦